In Vienna, a multi-faceted hot spot for life sciences has been established around the University of Natural Resources and Life Sciences (BOKU). As a central research partner for bioeconomy, BOKU contributes to knowledge-based production and use of biological resources in order to create a firm foundation for products, processes and services in all economic sectors. Its location in Muthgasse is a huge factor in terms of the development of biotechnology. Not only pioneering institutes of the university are to be found there, but also other research institutions such as the AIT - Austrian Institute of Technology and the Vienna site of the COMET K2 Centre “Austrian Centre of Industrial Biotechnology (acib).” Over the years, facilities like the University of Applied Sciences FH Campus Wien and the “Platform for Advanced Cellular Therapies (PACT)” have taken up the opportunity to settle there as well.
Lively start-up scene
The dynamics of the location are characterized by a pronounced entrepreneurial culture with a corresponding number of young companies. Hence, a lot of exciting success stories have begun here. Examples are immunotherapy developer S-TARget Therapeutics GmbH cooperating with Allergopharma, the Dutalys GmbH (which was bought up by F. Hoffmann-La Roche Ltd), the cell lines specialist Evercyte GmbH, the award-winning start-up TAmiRNA GesmbH and vaccine developer Themis Bioscience GmbH. In addition to these “red biotechnology” companies, a representative of the industrial biotechnology industry - Syconium Lactic Acid GmbH - has also established offices at the site. Another newcomer on-site is Platomics GmbH, a specialist in life science data analysis operating an app market place for life sciences.